Denosumab and Teriparatide Study (DATA-HD and DATA-EX)

NCT02176382 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

76

Enrollment

OTHER

Sponsor class

Conditions

Postmenopausal Osteoporosis

Interventions

DRUG: denosumab
DRUG: teriparatide
DRUG: Zoledronic acid

Sponsor

Massachusetts General Hospital